Rebamipide Prevents the Hemoglobin Drop Related to Mucosal-Damaging Agents at a Level Comparable to Proton Pump Inhibitors

키워드

참고문헌 (49)

1. Lanas A, "A review of the gastrointestinal safety data: a gastroenterologist’s perspective", Rheumatology (Oxford), 49(Suppl 2), pp.ii3~ii10 (2010)
2. Casado Arroyo R, "Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy : long-term follow-up of a cohort of patients commonly using PPI cotherapy", Heart, 98, pp.718~723 (2012)
3. Tsibouris P, "Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding", World J Gastrointest Endosc, 6, pp.612~619 (2014)
4. Shin SJ, "Non-steroidal anti-inflammatory drug-induced enteropathy", Intest Res, 15, pp.446~455 (2017)
5. Lanza FL, "Guidelines for prevention of NSAID-related ulcer complications", Am J Gastroenterol, 104, pp.728~738 (2009)
6. Kinoshita Y, "Advantages and disadvantages of long-term proton pump inhibitor use", J Neurogastroenterol Motil, 24, pp.182~196 (2018)
7. Wedemeyer RS, "Pharmacokinetic drug interaction profiles of proton pump inhibitors : an update", Drug Saf, 37, pp.201~211 (2014)
8. Yu LY, "A review of the novel application and potential adverse effects of proton pump inhibitors", Adv Ther, 34, pp.1070~1086 (2017)
9. Koch M, "Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury : a meta-analysis of randomized controlled clinical trials", Arch Intern Med, 156, pp.2321~2332 (1996)
10. Rostom A, "Prevention of NSAIDinduced gastroduodenal ulcers", Cochrane Database Syst Rev, (4), pp.CD002296~ (2002)
11. Satoh K, "Evidence-based clinical practice guidelines for peptic ulcer disease 2015", J Gastroenterol, 51, pp.177~194 (2016)
12. Joo MK, "Clinical guidelines for druginduced peptic ulcer, 2020 revised edition", Korean J Gastroenterol, 76, pp.108~133 (2020)
13. Watanabe T, "Current knowledge on non-steroidal anti-inflammatory drug-induced smallbowel damage : a comprehensive review", J Gastroenterol, 55, pp.481~495 (2020)
14. Edogawa S, "Current topics of strategy of NSAID-induced small intestinal lesions", Digestion, 92, pp.99~107 (2015)
15. Chan FK, "Risks of bleeding recurrence and cardiovascular events with continued aspirin use after lower gastrointestinal hemorrhage", Gastroenterology, 151, pp.271~277 (2016)
16. Kim TJ, "Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal antiinflammatory drug users", Sci Rep, 9, pp.11696~ (2019)
17. Niwa Y, "Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects : a prospective, randomized, doubleblinded, placebo-controlled, cross-over study", J Gastroenterol, 43, pp.270~276 (2008)
18. Goldstein JL, "Haemoglobin decreases in NSAID users over time : an analysis of two large outcome trials", Aliment Pharmacol Ther, 34, pp.808~816 (2011)
19. Laine L, "Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use", Gastroenterology, 124, pp.288~292 (2003)
20. Lanas A, "Risk factors associated with a decrease ≥2 g", dL in haemoglobin and, Aliment Pharmacol Ther, pp.2012, 36[DOI]
21. Anderson JR, "Analysis of survival by tumor response", J Clin Oncol, 1, pp.710~719 (1983)
22. Whitaker HJ, "Tutorial in biostatistics : the self-controlled case series method", Stat Med, 25, pp.1768~1797 (2006)
23. Petersen I, "Self controlled case series methods : an alternative to standard epidemiological study designs", BMJ, 354, pp.i4515~ (2016)
24. Abdul-Hussein M, "Concomitant administration of a histamine2 receptor antagonist and proton pump inhibitor enhances gastric acid suppression", Pharmacotherapy, 35, pp.1124~1129 (2015)
25. Cho HY, "Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets : a randomized, single-dose, two-period, twosequence crossover study in healthy Korean male volunteers", Clin Ther, 31, pp.2712~2721 (2009)
26. Hasegawa S, "Bioequivalence of rebamipide granules and tablets in healthy adult male volunteers", Clin Drug Investig, 23, pp.771~779 (2003)
27. Dunne CL, "30-Day readmission rates among upper gastrointestinal bleeds : a systematic review and meta-analysis", J Gastroenterol Hepatol, 38, pp.692~702 (2023)
28. Lau JY, "Timing of endoscopy for acute upper gastrointestinal bleeding", N Engl J Med, 382, pp.1299~1308 (2020)
29. Dafni U, "Landmark analysis at the 25-year landmark point", Circ Cardiovasc Qual Outcomes, 4, pp.363~371 (2011)
30. Rao P, "Evolution of nonsteroidal anti-inflammatory drugs(NSAIDs) : cyclooxygenase(COX)inhibition and beyond", J Pharm Pharm Sci, 11, pp.81s~110s (2008)
31. Vane JR, "Anti-inflammatory drugs and their mechanism of action", Inflamm Res, 47(Suppl 2), pp.S78~S87 (1998)
32. Bacchi S, "Clinical pharmacology of non-steroidal anti-inflammatory drugs : a review", Antiinflamm Antiallergy Agents Med Chem, 11, pp.52~64 (2012)
33. Bjarnason I, "Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs", Gastroenterology, 154, pp.500~514 (2018)
34. Lanas A, "Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants", Am J Gastroenterol, 102, pp.507~515 (2007)
35. Washio E, "Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury : a randomized, placebocontrolled trial", Clin Gastroenterol Hepatol, 14, pp.809~815 (2016)
36. Lo WK, "Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth : a meta-analysis", Clin Gastroenterol Hepatol, 11, pp.483~490 (2013)
37. Endo H, "Risk factors for smallbowel mucosal breaks in chronic low-dose aspirin users : data from a prospective multicenter capsule endoscopy registry", Gastrointest Endosc, 80, pp.826~834 (2014)
38. Wallace JL, "Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis", Gastroenterology, 141, pp.1314~1322 (2011)
39. Wallace JL, "NSAID gastropathy and enteropathy : distinct pathogenesis likely necessitates distinct prevention strategies", Br J Pharmacol, 165, pp.67~74 (2012)
40. Otani K, "Microbiota plays a key role in non-steroidal anti-inflammatory drug-induced small intestinal damage", Digestion, 95, pp.22~28 (2017)
41. Scarpignato C, "Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis : an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks", BMC Med, 13, pp.55~ (2015)
42. Snook J, "British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults", Gut, 70, pp.2030~2051 (2021)
43. Kim JH, "Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory druginduced mucosal toxicity", Gut Liver, 8, pp.371~379 (2014)
44. Tozawa K, "A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel", Dig Dis Sci, 59, pp.1885~1890 (2014)
45. Kurokawa S, "A randomized, doubleblinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and", or nonsteroidal anti-inflammatory drug induced small bowel injury, 2014, pp.49, 239~244
46. Watanabe T, "A multicenter, randomized, double-blind, placebo-controlled trial of highdose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage", PLoS One, 10, pp.e0122330~ (2015)
47. Kurata S, "Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model", J Clin Biochem Nutr, 56, pp.20~27 (2015)
48. Tanigawa T, "Rebamipide inhibits indomethacin-induced small intestinal injury : possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5", Eur J Pharmacol, 704, pp.64~69 (2013)
49. Zhang WT, "Inhibition of aspirininduced gastrointestinal injury : systematic review and network meta-analysis", Front Pharmacol, 12, pp.730681~ (2021)

관련 논문AI추천